LARONIDASE vs LAROTRECTINIB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
LARONIDASE vs LAROTRECTINIB: Safety Overview
| Metric | LARONIDASE | LAROTRECTINIB |
|---|---|---|
| Total FAERS Reports | 3,089 | 798 |
| Deaths Reported | 430 | 149 |
| Death Rate | 13.9% | 18.7% |
| Hospitalizations | 987 | 151 |
| Average Patient Age | 14.7 yrs | 48.9 yrs |
| % Female Patients | 50.5% | 51.5% |
| FDA Approval Date | N/A | Nov 26, 2018 |
| Manufacturer | Genzyme Corporation | Bayer HealthCare Pharmaceuticals Inc. |
| Route | INTRAVENOUS | ORAL |
| Marketing Status | Prescription | Prescription |